Skip to main content

Steven Epstein

  • Managing Partner | Co-Head, M&A and Private Equity

New York

T: +1.212.859.8964

Headshot of Steven Epstein

Steve Epstein is the managing partner of the firm and a member of the firm’s Governance Committee. He maintains an active corporate practice and serves as a trusted advisor to some of the country’s leading companies across a broad range of industry sectors. As co-head of our M&A and Private Equity Practice, Steve counsels public and private companies, financial sponsors and investment banking firms in a variety of transactional and advisory situations, including acquisitions, divestitures, takeover preparedness and corporate governance matters. Steve brings extensive knowledge and experience from different deal-making perspectives, having advised clients both as an attorney and, previously, as an investment banker at Credit Suisse.

Steve’s practice has earned him accolades from Chambers USA as an “Eminent Practitioner” in Corporate/M&A and as a leading individual in Legal 500 and Super Lawyers. He was named a BTI “Client Service All-Star” for 2020, 2021 and 2024 and has been recognized in NACD’s “Directorship 100” as a leading advisor to corporate boards. He was previously named a Rockefeller Fellow by the Partnership for New York City.

Sought after as a thought leader in the space, Steve speaks frequently and writes extensively on developments in M&A and on emerging corporate governance trends.

Select Work Highlights:

• Apollo Global Management in numerous engagements, including advising the Special Committee of the Board of Directors of Apollo Commercial Real Estate Finance in the sale of its entire $9 billion commercial real estate loan portfolio to Athene.
• Tradeweb in its $785 million acquisition of Institutional Cash Distributors, LLC (ICD), an institutional investment technology provider for corporate treasury organizations trading short-term investments.
• Broadcast Music Inc. (BMI) in its sale to a shareholder group led by New Mountain Capital.
• CVS Health and its subsidiary, CaremarkPCS, in the sale of a majority of CVS’s equity stake in Surescripts to TPG.
• Leidos Holdings in its $1 billion acquisition of L3Harris' Security Detection and Automation businesses, and in the $170 million sale of its commercial cybersecurity business to Capgemini America, Inc.
• Catalent in numerous engagements, including its $1 billion acquisition of Bettera Holdings, its $1.2 billion acquisition of Paragon Bioservices, its $950 million acquisition of Cook Pharmica, its $475 million acquisition of Metrics Contract Services, and its acquisitions of Redwood Bioscience, Micron Technologies, Accucaps Industries Limited, MaSTherCell Global, and Vaccine Manufacturing and Innovation Centre UK Limited.
•  Becton, Dickinson and Company  in numerous engagements, including its acquisitions of TVA Medical, Scanwell Health Inc., ZebraSci, Inc. and Tepha, Inc.


Steve received his JD from Fordham University Law School in 1998, where he was a Stein Scholar and member of the Fordham International Law Journal. He also currently serves on the Board of Directors of Fordham University School of Law. Steve received his BS from Cornell University in 1994. Steve is admitted to practice in New York.

 

Professional associations

  • Member, General Counsel Steering Committee, National Association of Corporate Directors (NACD)
  • Member, Association of the Bar of the City of New York
  • Committee Member, Mergers, Acquisitions & Corporate Control Contests, New York City Bar Association
  • Corporate Governance Fellow, National Association of Corporate Directors (NACD)
  • Member, Board of Directors, Fordham University School of Law
  • Member, New York State Bar Association

News and insight

Events

Speaking engagement |

NACD’s “Leading Minds of Governance” Panel⟶

Speaking engagement |

NACD’s Leading Mind Series: M&A⟶

Speaking engagement |

Harvard Corporate Governance Roundtable⟶
Back to top ↑